Navigating Cross-Border eDiscovery in the Pharmaceutical Industry Why It
Matters
Operating globally across multiple jurisdictions, pharmaceutical companies must protect sensitive patient data, clinical trial information, and intellectual property while navigating some of the world’s most demanding regulatory frameworks.
When litigation or regulatory inquiries arise, these organizations must manage not just the volume of data but also its movement across borders.
Conflicting international privacy obligations, strict data sovereignty rules, and demanding regulatory regimes can make cross-border eDiscovery one of the most challenging aspects of legal and compliance work in the pharma sector. Non-compliance carries steep risks: financial penalties, regulatory sanctions, and reputational damage. To navigate these challenges, companies should adopt a strategic, legally defensible framework aligned with recognized standards such as The Sedona Conference’s International Principles on Discovery, Disclosure, and Data Protection (Second Edition, 2017) and its Practical In-House Approaches for Cross Border Discovery & Data Protection (2016).
Fill out the form to access content
By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Integreon products, services, and events. The data sent will be processed in Canada and provided to Integreon who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal below.